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An ECG every 3 years is enough to follow patients with myotonic dys-
trophy
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Patients (pts) with type I myotonic dystrophy (MD) were reported as at
high risk of arrhythmias, mainly conduction disturbances. The purpose of the
study was to evaluate the mean time of change of noninvasive investigations
and to propose recommendations for the follow-up of patients with MD. 
Methods: 129 asymptomatic pts, mean age 41±14 years, with MDl, were
consecutively recruited. ECG, left ventricular ejection fraction (EF) determina-
tion, Holter monitoring, were obtained and repeated each year in pts without
conduction abnormalities. Electrophysiological study (EPS) was performed in
51 pts. Follow-up duration ranged from 1 to 23 years, with a mean duration of
10 ± 5 years. 
Results: At initial study, ECG and Holter monitoring were normal in 72
and 89 pts; EF was normal in all but 6 pts (60±10.5 %). At the last study, the
ECG did not change in 65 % of pts; in 49 pts with normal ECG, the ECG
remained normal in 32 pts; first degree (d) AV block (B) developed in 11 pts,
left hemiblock (HB) in 3 pts, complete bundle branch block (BBB) in 3 pts; 3
pts with a BBB developed another localization of conduction disturbance. HV
increase was noted in patients with first d AVB and HB or BBB, and never in
pts with normal ECG. Initially normal Holter monitoring (n=61) remained
normal in 44 pts (72 %); sinus pauses were noted in 6 pts and non sustained
ventricular tachycardia in one pt. In 19 pts with initial abnormalities, Holter
monitoring became normal in 10 of them. LVEF did not change significantly
(61±11 at first study, 58±11 % at 2nd study). The ECG modifications deve-
loped after a mean follow-up of 5 ±1 years. The shorter time of the occurrence
of a significant modification was 4 years. However, to be sure to detect a
significant change and risk of arrhythmias, a period of 3 years (5± 2 standard
deviations) could be retained.
Conclusions: HV increase was noted only in patients with abnormal ECG.
No change of ECG was noted in patients with normal ECG before 4 years.
The repetition of ECG every 3 years is recommended and EPS should be indi-
cated when ECG became abnormal.
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Objective: Define the prognosis value of the congestive clinical signs of
heart failure (CHF) in an out-patient clinic compared to other clinical variables.
Background: Clinical examination is non-specific to diagnose CHF.
However the prognosis value of the clinic signs of CHF is unknow.
Methods: Analysis of referrals to a community clinic of suspected chronic
heart failure with a clinical examination. Clinical signs of CHF were defined
as no sign, fluid retention (FR; oedema, ascitis, hepatomegaly, jugular vein
distension), lung crackles (LC) and their combination (FR+LC). Systolic heart
failure was defined as LVEF<45% (S-HF), CHF with normal ejection fraction
was defined as LVEF ≥45% and NT-proBNP>50pmol.l-1 (HeFNEF), others
were defined as No-HF. 
Results: Of 1881 patients referred, 853 patients had S-HF, 321 had HeFNEF
and 707 No-HF. Their median (IQR) age was 72yrs (64-78), LVEF was 47%
(35-59) and 40% were women. 1207 patients had no clinical signs of CHF of
whom 41% were SHF and 16% HeFNEF, 85 had LC of whom 43% were S-HF
and 20% HeFNEF, 417 had FR of whom 49% had S-HF and 21% HeFNEF and
172 had LC+Frof whom 43% had S-HF and 16% HeFNEF. Patients with
LC+RF were more breathless, had more frequently an ischaemic heart disease
and had a lower ejection fraction and a lower right ventricle function measured
by the tricupsid annular plane systolic excursion. During a median (IQR) follow
up of 64 (44-76) months, mortality was 40%. In multivariable analysis,
increasing age, NYHA class, heart rate, LC+FR, FR, ischaemic heart disease and
chronic obstructive pulmonary disease predicted an adverse prognosis;
increasing diastolic blood pressure and female sex predicted a better outcome.
Using Kaplan Meier curves, LC and FR indicated a similar bad prognosis,
LC+FR indicated the worse prognosis when all the patients were considered (log
Rank=185, p<0.0001), or the three HF groups separately.
Conclusion: Clinical signs of CHF are powerful predictors of prognosis in
outpatient clinic. Presence of fluid retention and lung crackles showing the
worse prognosis. These clinical signs should be assessed systematically to eva-
luate the prognosis in symptomatic patients.
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Patterns of acute heart failure in nonagenarians
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Background: Since heart failure (HF) often occurs in subjects >70y old
and the population of Western countries is getting older, the incidence of HF
is expected to dramatically increase in the future. However, limited informa-
tion is available on HF in the extreme elderly. 
Methods: We retrospectively studied patients >90y old patients admitted to
our hospital for acute HF between 2007 and March 2010. Patients with incomplete
clinical records were excluded. Main foci were : epidemiological data, initial pre-
sentation, results of routine biological and imaging tests and clinical outcome.
Results: 56 patients (mean age 94 [range 91-97], 60% female) were
included. Cardiovascular risk factors were hypertension (75%), hypercholeste-
rolemia (16%) and diabetes (7%). 56% of patients had no underlying cardio-
myopathy while 16% had coronary artery disease, 13% had valve disease, 5%
had hypertension and 10% had cardiomyopathy due to multiple factors. On
presentation, mean creatinine was 163 mmol/L [79-317], hemoglobin was 11,5
g/dL [9,9-12,4], and BNP was 2617 pg/mL [128-14.574]. Mean ejection frac-
tion was 46% [34-58]. The 3 main precipitating factors of acute HF were
hypertension (23%), infection (23%) and acute coronary syndrome (20%). In
15% of patients, no reason for acute decompensation could be identified. More
than 50% of patients were admitted to the ICU, 30% required breathing assis-
tance and 5% required inotropic drugs. Average hospital stay was 6 days [2.9-
9.5]. 63% of patients were discharged home; hospital mortality was 20%.
Medical treatment at discharge included diuretics (90%), ACE inhibitors
(60%) and beta-blockers (45%). 
Conclusion: Acute HF in nonagenarians is associated with poor prognosis.
Main characteristics are a preserved ejection fraction, no obvious underlying
cardiomyopathy and infection and hypertension as precipitating factors.
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Introduction: A heart failure with preserved ejection fraction ( HFPEF) is
present in half the patients with heart failure (HF); the prognosis in more
recent studies has been shown to be essentially similar to that of systolic HF.
The objective of our study is to define the clinical, biological and echocardio-
graphic predictors of outcome in patients with HFPEF. 
Material and methods: We included 1200 patients, admitted in Ibn Rochd
Center of Cardiology from May 2006 to February 2010. HFPEF was defined
as LVEF ≥ 45% and receiving a loop diuretic for breathlessness. All patients
were evaluated clinically with monitoring of blood pressure (BP), 6 min walk
test and electrocardiogram. Two-dimensional echocardiography and laboratory
tests were performed in all patients.
Results: Of 1200 patients, 63 ( 5.25%) had HFPEF; the median age was 66
years ( 42- 94) and 61.9% were men. 49.2% of the patients were hypertensive
